2018-02-24, Sat.

Top Stories       Business       Culture & Life       Science & Technology       World

Lecture

Notification

 

NEWS > Business


Boehringer Ingelheim: Nine out of 10 AF patients are concerned about stroke and many want to be part of OAC treatment decisions, new international sur

“For the first time, we have in-depth data about the perceptions and treatment preferences of AF patients across multiple countries”
Date: 2016-05-11

  • First-of-its-kind survey investigated knowledge of stroke and perceptions about atrial fibrillation (AF) in over 900 AF patients1,2
  • Results show that patients actively seek information about treatments to reduce the risk of stroke associated with AF1,2
  • Many patients want to be involved in the decision-making process about which oral anticoagulant (OAC) to take1,2
  • INGELHEIM, Germany--()--Nine out of 10 patients with atrial fibrillation (AF) surveyed were concerned about the risk of a stroke.1 Oral anticoagulant (OAC) treatments are usually prescribed to reduce this risk3 and the vast majority of patients actively sought information about their treatment.1,2 Many patients even wanted to be involved in the choice of the oral anticoagulant.1,2 These, and further results from a first-of-its-kind international survey of over 900 AF patients, were presented at the 2nd European Stroke Organisation Conference, 10–12 May in Barcelona.1,2

    For the first time, we have in-depth data about the perceptions and treatment preferences of AF patients across multiple countries,” comments Dr Deirdre Lane, Senior Lecturer in Cardiovascular Health at the University of Birmingham, UK, who led the research. “One key result of the survey is that many AF patients want to be involved in the decision about their oral anticoagulant treatment. This desire mirrors recommendations in current professional guidelines, which call for a consideration of patient values and preferences when choosing oral anticoagulant therapy.”

    The survey highlighted the importance of the interaction between patients and their treating physician: for over three quarters (76%) of AF patients, their doctor was the key source of information on their OAC treatment.2 On average, patients consulted two to three information sources in total.2 Still, patients’ knowledge of the causes, signs and symptoms of stroke was inconsistent – only about half (48%) of AF patients have good or moderate knowledge of stroke symptoms, causes and risk factors.1,2

    Stroke knowledge influenced a number of patient preferences. Patients with good or moderate stroke knowledge:

    • ranked stroke prevention higher as an important factor in the choice of their OAC (65% and 54% vs. an average of 47%)2
    • preferred to be involved in the decision about the OAC treatment more often (73% and 62% vs. an average of 56%).2

    “Strokes related to AF are particularly severe – they can be fatal and survivors may be left with significant disability requiring life-long care,” advises Jon Barrick, President of the Stroke Alliance for Europe. “It is crucial that AF patients are empowered to actively participate in the management of their own condition, especially as AF is a chronic disease, which requires continuous treatment. An open dialogue with their doctors about their condition, how to manage it, and which treatments to take to reduce their risk of stroke is one crucial element of that.”

    This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.



     to the Top List of News

    Samsung Selected as a 4G LTE Open RAN Provider on Verizon’s 4G LTE Network
    Samsung Launches Samsung Max, a Unique Android Application Offering Mobile Data Saving Mode and Privacy Protection Mode
    Samsung Electronics and Qualcomm Expand Foundry Cooperation on EUV Process Technology
    KT, Qualcomm and Samsung Achieve Multi-vendor 5G NR Interoperability on Path to Mobile 5G NR Trials in 2018
    Samsung and Cisco Team With Orange for First Multi-Vendor 5G Fixed Wireless Trial in Europe
    KT, Verizon and Samsung Collaborate to Demonstrate and Advance Next Level of 5G Innovation
    SK Telecom Announces 2017 Earnings Results

     

    LEADING DIGITAL SIGNAGE PRODUCTS FROM LG DELIVER OPTIMIZED VERTICAL SO...
    Samsung Electronics Partners with World’s Largest Theater Operator, W...
    LG AND HONEYWELL DEMO AUTOMOTIVE CYBERSECURITY SOLUTION
    Samsung Electronics Announces Stock Split And Shareholder Return
    Samsung Pay Now Available in Mexico
    Samsung Strengthens its Foundry Customer Support with New SAFETM Found...
    LG ANNOUNCES 2017 FINANCIAL RESULTS

     

     

    60, Gamasanro 27gil, Guro-gu, Seoul, Korea, e-mail: news@newsji.com

    Copyright, The News Group